+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Point of Care & Rapid Diagnostics Market by Product (Glucose, Infectious Disease (HIV, Hepatitis C), Pregnancy Test), Platform (Microfluidics, Dipsticks), Mode of Purchase (OTC, Prescription), End User (Pharmacy, Hospital, Home) - Forecast to 2027

  • ID: 5292861
  • Report
  • March 2022
  • Region: Global
  • 359 Pages
  • Markets and Markets
Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints

FEATURED COMPANIES

  • Abbott
  • Biocartis
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Lifescan Ip Holdings, LLC
  • Nova Biomedical
The global point of care diagnostics market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027. Point-of-care testing (POCT) includes screening or diagnostic tests performed outside traditional laboratories. These tests are designed to be used at or near the site where the patient is located (such as at home, in an ambulance, at a physician’s office, and other locations). POCT allows rapid and reliable diagnostic testing through which outcomes can be obtained instantly, helping physicians/patients to make decisions related to care remotely and as soon as possible. Market growth is mainly driven by the high prevalence of infectious diseases, supportive government policies and rising number of CLIA-waived POC tests. In addition, healthcare decentralization and greater investments and funding for product development are expected to offer growth opportunities for players in the point of care diagnostics market. POC tests can greatly improve the management of infectious diseases, especially in developing countries where access to timely medical care is a challenge and the healthcare infrastructure is antiquated and sparse.



According to UNAIDS, around 20.6 million people were living with HIV in East and Southern Africa in 2018. In 2019, 20,000 new HIV cases were registered in the Middle East and North Africa (Source: UNAIDS Data 2020). In the Asia Pacific, an estimated 5.8 million people were suffering from HIV in 2019, led by India and China. According to UNAIDS, in 2019, approximately 2.1 million people in India were infected with HIV. The high prevalence of HIV is likely to boost the demand for point-of-care diagnostics, further accelerating the treatment of HIV infection. 

Listed below are important statistics related to major infectious diseases in developing countries:


  • According to the WHO, India has the highest tuberculosis burden, with an estimated incidence of 2.64 million cases in 2020
  • In 2019, around 4.3 million new tuberculosis cases were reported in Southeast Asia, and 632,000 people died due to TB infections in this region (Source: WHO)
  • According to the National Influenza Policy 2017, around 10,000 deaths and 40,000 hospitalizations are caused due to influenza in South Africa each year
  • According to the WHO, 1.2 million people in Southeast Asia suffer from malaria, with India alone accounting for ~76% of the total malaria cases
  • During 2014 - 2016, West Africa reported the largest Ebola epidemic in the region; in two and a half years, the outbreak resulted in more than 28,600 cases and 11,325 deaths
  • In 2020, an estimated 15,898 people in Brazil were at risk of Zika virus infections, down from over 30,000 cases reported a year earlier


The high prevalence of infectious diseases, coupled with the inadequate healthcare infrastructural facilities in developing countries, is expected to drive the adoption of POC testing.

The Glucose Monitoring Products segment accounted for the largest share of the point of care diagnostics market, by product type, in 2021


Based on products, the point-of-care diagnostics market is segmented into glucose monitoring products, cardiometabolic monitoring products, COVID-19 testing products, infectious disease testing products, coagulation monitoring products, pregnancy & fertility testing products, hematology testing products, tumor/cancer marker testing products, fecal occult testing products, urinalysis testing products, drug-of-abuse testing products, cholesterol testing products, and other products. In 2021, the glucose monitoring products segment accounted for the largest share of the point-of-care diagnostics market. This can be attributed to the growing diabetic patient population base, ongoing technological advancements, and the growing preference for home glucose testing.

The Lateral Flow Assays segment accounted for the largest share of the point of care diagnostics market, by platform, in 2021


Based on platform, the point-of-care diagnostics market is segmented into lateral flow assays, immunoassays, microfluidics, dipsticks, and molecular diagnostics. The lateral flow assays segment accounted for the largest share of the market in 2021. The widespread adoption of lateral flow assays in POC testing as a replacement for lengthy, conventional laboratory procedures is a key factor contributing to the growth of this segment.


The OTC Testing Products segment, by mode of purchase, accounted for the largest share of the global point of care diagnostics market in 2021


On the basis of mode of purchase, the point-of-care diagnostics market is segmented into OTC testing products and prescription-based testing products. The OTC testing products segment accounted for the largest share of the market in 2021. The growing prevalence of lifestyle diseases and the favorable reimbursement scenario for OTC testing products are the major factors driving the growth of this market segment.

On the basis of End Users, Hospitals & Critical Care Centers segment accounted for the largest share of the global point of care diagnostics market, in 2021


On the basis of end users, the point-of-care diagnostics market is segmented into clinical laboratories; ambulatory care facilities and physicians’ offices; pharmacies, retail clinics, and E-commerce platforms; hospitals, critical care centers, and urgent care centers; home care & self-testing; and other end users. The hospitals & critical care centers segment is expected to dominate the market during the forecast period, owing to the increasing adoption of POC devices offering reduced turnaround time. The clinical laboratories segment accounted for the largest share of the point-of-care diagnostics market in 2021. However, the home care and self-testing segment is projected to register the highest CAGR during the forecast period, owing to the increasing prevalence of chronic diseases (requiring long-term care and frequent monitoring), growing awareness about home care, and the increasing availability of user-friendly and advanced POC diagnostic products.

The Latin America market is expected to grow at the highest CAGR during the forecast period


The global point of care diagnostics market is segmented into North America (comprising the US and Canada), Europe (includes Germany, France, and the UK), the Asia Pacific (includes Japan, China, India), Latin America (Brazil, Mexico), and the Middle East & Africa. In 2021, North America accounted for the largest share of this market, followed by Europe. The rising prevalence of lifestyle diseases, growing number of product approvals, and government initiatives to support the wider adoption of POC testing products are the key factors driving the growth of the North American point-of-care diagnostics market. On the other hand, the Latin American market is projected to register the highest growth during the forecast period due to government efforts to increase awareness about the early detection of diseases and regular health check-ups, further promoting point-of-care devices.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 - 48%, Tier 2 - 36%, and Tier 3 - 16%
  • By Designation: C-level - 10%, Director-level - 14%, and Others - 76%
  • By Region: North America - 40%, Europe - 32%, Asia Pacific - 20%, Latin America - 5%, and the Middle East & Africa - 3%


As of 2020, the point of care diagnostics market is dominated by Roche Diagnostics (Switzerland), Abbott Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Quidel Corporation (US). Other leading players are Becton, Dickinson, and Company (US), Biomeriux S.A. (France), and Chembio Diagnostics (US).

Research Coverage


This report studies the point of care diagnostics market based on product type, platform, mode of purchase, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report


The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:


  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the point of care diagnostics market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the point of care diagnostics market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the point of care diagnostics market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
Frequently Asked Questions about the Global Point of Care and Rapid Diagnostics Market

What is the estimated value of the Global Point of Care and Rapid Diagnostics Market?

The Global Point of Care and Rapid Diagnostics Market was estimated to be valued at $43.2 Billion in 2022.

What is the growth rate of the Global Point of Care and Rapid Diagnostics Market?

The growth rate of the Global Point of Care and Rapid Diagnostics Market is 10.8%, with an estimated value of $72.0 Billion by 2027.

What is the forecasted size of the Global Point of Care and Rapid Diagnostics Market?

The Global Point of Care and Rapid Diagnostics Market is estimated to be worth $72.0 Billion by 2027.

Who are the key companies in the Global Point of Care and Rapid Diagnostics Market?

Key companies in the Global Point of Care and Rapid Diagnostics Market include A. Menarini Diagnostics S.R.L, Abbott, Accubiotech Co., Ltd., Acon Laboratories, Inc., Ascensia Diabetes Care Holdings Ag, Becton, Dickinson and Company, Biocartis, Biomérieux S.A. and Danaher Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Biocartis
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Lifescan Ip Holdings, LLC
  • Nova Biomedical

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Major Market Stakeholders
1.6 Summary of Changes
2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
Figure 2 Breakdown of Primaries: Point-Of-Care Diagnostics Market
2.2 Market Estimation Methodology
Figure 3 Research Methodology: Hypothesis Building
2.2.1 Revenue Mapping-Based Market Estimation
2.2.2 End-user-Based Market Estimation
Figure 4 Market Size Estimation: Point-Of-Care Diagnostics Market
2.2.3 Primary Research Validation
2.3 Data Triangulation
Figure 5 Data Triangulation Methodology
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary
Figure 6 Point-Of-Care Diagnostics Market, by Product, 2020 Vs. 2025 (USD Million)
Figure 7 Point-Of-Care Diagnostics Market, by Platform, 2020 Vs. 2025 (USD Million)
Figure 8 Point-Of-Care Diagnostics Market, by Mode of Purchase, 2020 Vs. 2025 (USD Million)
Figure 9 Point-Of-Care Diagnostics Market, by End-user, 2020 Vs. 2025 (USD Million)
Figure 10 Geographical Snapshot of the Point-Of-Care Diagnostics Market
4 Premium Insights
4.1 Point-Of-Care Diagnostics Market Overview
Figure 11 Increasingly Supportive Government Policies and Rising Prevalence of Target Diseases Are Driving the Market Growth
4.2 Point-Of-Care Diagnostics Market, by Mode of Purchase, 2020
Figure 12 OTC Testing Products Dominate the Point-Of-Care Diagnostics Market in 2020
4.3 Asia-Pacific: Point-Of-Care Diagnostics Market
Figure 13 Home Care Settings Were the Largest End-User Segment in the APAC Poc Diagnostics Market in 2020
4.4 Point-Of-Care Diagnostics Market, by Region
Figure 14 APAC to Register the Highest Growth During the Forecast Period (2020-2025)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 15 Point-Of-Care Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 High Prevalence of Infectious Diseases
5.2.1.2 Increasing Incidence of Target Conditions
5.2.1.3 Supportive Government Policies
5.2.1.4 Dearth of Skilled Laboratory Technicians
5.2.1.5 Rising Number of Clia-Waived Poc Tests
Table 1 Recent Waivers for Market Products
5.2.2 Restraints
5.2.2.1 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
5.2.2.2 Stringent Regulatory Policies
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Healthcare Decentralization
5.2.3.3 Increasing Provider Awareness About Novel Technologies
5.2.3.4 Poc Tests with Multiplexing Capabilities
5.2.3.5 Growing Investments and Funding for Product Development
5.2.4 Challenges
5.2.4.1 Lack of Alignment with Definitive Central Lab Methods
5.2.4.2 Inadequate Adoption of Poc Devices in Professional Settings
5.2.4.3 Reluctance to Change Existing Diagnostic Practices
5.2.4.4 Premium Pricing of Novel Platforms
5.3 Technology Analysis: Emerging Point-Of-Care Applications
5.3.1 Sepsis Biomarkers
5.3.2 Stroke/Cardiac Markers
5.3.3 Thyroid Testing
5.3.4 DNA Testing
5.3.5 Endocrine Testing
5.3.6 Respiratory Diagnostics
5.4 Global Regulatory Landscape
5.5 Industry Trends Related to COVID-19
5.6 Value Chain Analysis
Figure 16 Value Chain Analysis - Maximum Value Added During the Regulation and Distribution Stages
5.7 Pricing Trend Analysis
Table 2 Average Price of Glucose Monitoring and Cardiometabolic Monitoring Products, by Country, 2019 (USD)
Table 3 Average Price of Infectious Disease Testing Products, by Country, 2019 (USD)
Table 4 Average Price of Other Point-Of-Care Testing Products, by Country, 2019 (USD)
5.8 Ecosystem Coverage: Parent Market (In Vitro Diagnostics)
5.9 Use Cases: Point-Of-Care Diagnostics Market
5.9.1 Revenue Opportunities: IVD Assay Development Services
5.9.2 Revenue Opportunities: IVD Contract Research Services
6 Point-Of-Care Diagnostics Market, by Product
6.1 Introduction
Table 5 Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
6.2 Glucose Monitoring Products
Table 6 Point-Of-Care Diagnostics Market for Glucose Monitoring Products, by Type, 2018-2025 (USD Million)
Table 7 Point-Of-Care Diagnostics Market for Glucose Monitoring Products, by Platform, 2018-2025 (USD Million)
Table 8 Point-Of-Care Diagnostics Market for Glucose Monitoring Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 9 Point-Of-Care Diagnostics Market for Glucose Monitoring Products, by End-user, 2018-2025 (USD Million)
Table 10 Point-Of-Care Diagnostics Market for Glucose Monitoring Products, by Region, 2018-2025 (USD Million)
6.2.1 Strips
6.2.1.1 Strips Make Blood Glucose Testing Easy and Hassle-Free
Table 11 Glucose Monitoring Strips Market, by Region, 2018-2025 (USD Million)
6.2.2 Meters
6.2.2.1 Blood Glucose Meters Are Extremely Helpful in the Monitoring of Blood Glucose Levels and Adjusting Therapeutic Regimens
Table 12 Glucose Monitoring Meters Market, by Region, 2018-2025 (USD Million)
6.2.3 Lancets & Lancing Devices
6.2.3.1 Lancets & Lancing Devices Segment to Grow at the Lowest CAGR in the Glucose Monitoring Products Market
Table 13 Glucose Monitoring Lancets & Lancing Devices Market, by Region, 2018-2025 (USD Million)
6.3 Cardiometabolic Monitoring Products
Table 14 Point-Of-Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2018-2025 (USD Million)
Table 15 Point-Of-Care Diagnostics Market for Cardiometabolic Monitoring Products, by Platform, 2018-2025 (USD Million)
Table 16 Point-Of-Care Diagnostics Market for Cardiometabolic Monitoring Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 17 Point-Of-Care Diagnostics Market for Cardiometabolic Monitoring Products, by End-user, 2018-2025 (USD Million)
Table 18 Point-Of-Care Diagnostics Market for Cardiometabolic Monitoring Products, by Region, 2018-2025 (USD Million)
6.3.1 Cardiac Marker Testing Products
6.3.1.1 Rising Government Initiatives for Cvd Research Will Contribute to Market Growth
Table 19 Point-Of-Care Diagnostics Market for Cardiac Marker Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 20 Point-Of-Care Diagnostics Market for Cardiac Marker Testing Products, by End-user, 2018-2025 (USD Million)
Table 21 Point-Of-Care Diagnostics Market for Cardiac Marker Testing Products, by Region, 2018-2025 (USD Million)
6.3.2 Blood Gas/Electrolyte Testing Products
6.3.2.1 Technological Advancements in Blood Gas/Electrolyte Products Will Drive the Growth of this Market Segment
Table 22 Point-Of-Care Diagnostics Market for Blood Gas/Electrolyte Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 23 Point-Of-Care Diagnostics Market for Blood Gas/Electrolyte Testing Products, by End-user, 2018-2025 (USD Million)
Table 24 Point-Of-Care Diagnostics Market for Blood Gas/Electrolyte Testing Products, by Region, 2018-2025 (USD Million)
6.3.3 Hba1C Testing Products
6.3.3.1 Government Initiatives Are Promoting the Regular Use of Hba1C Testing
Table 25 Point-Of-Care Diagnostics Market for Hba1C Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 26 Point-Of-Care Diagnostics Market for Hba1C Testing Products, by End-user, 2018-2025 (USD Million)
Table 27 Point-Of-Care Diagnostics Market for Hba1C Testing Products, by Region, 2018-2025 (USD Million)
6.4 Infectious Disease Testing Products
Table 28 Point-Of-Care Diagnostics Market for Infectious Disease Testing Products, by Type, 2018-2025 (USD Million)
Table 29 Point-Of-Care Diagnostics Market for Infectious Disease Testing Products, by Platform, 2018-2025 (USD Million)
Table 30 Point-Of-Care Diagnostics Market for Infectious Disease Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 31 Point-Of-Care Diagnostics Market for Infectious Disease Testing Products, by End-user, 2018-2025 (USD Million)
Table 32 Point-Of-Care Diagnostics Market for Infectious Disease Testing Products, by Region, 2018-2025 (USD Million)
6.4.1 Hiv Testing Products
6.4.1.1 Rising Prevalence of Hiv to Drive Market Growth
Table 33 Point-Of-Care Diagnostics Market for Hiv Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 34 Point-Of-Care Diagnostics Market for Hiv Testing Products, by End-user, 2018-2025 (USD Million)
Table 35 Point-Of-Care Diagnostics Market for Hiv Testing Products, by Region, 2018-2025 (USD Million)
6.4.2 Respiratory Infection Testing Products
6.4.2.1 Poct Products for the Diagnosis of Respiratory Infections Offer Lower Sensitivity as Compared to Other Tests
Table 36 Point-Of-Care Diagnostics Market for Respiratory Infection Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 37 Point-Of-Care Diagnostics Market for Respiratory Infection Testing Products, by End-user, 2018-2025 (USD Million)
Table 38 Point-Of-Care Diagnostics Market for Respiratory Infection Testing Products, by Region, 2018-2025 (USD Million)
6.4.3 Hepatitis C Testing Products
6.4.3.1 Central and East Asia Are Among the Highly Affected Regions with Hepatitis C
Table 39 Point-Of-Care Diagnostics Market for Hepatitis C Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 40 Point-Of-Care Diagnostics Market for Hepatitis C Testing Products, by End-user, 2018-2025 (USD Million)
Table 41 Point-Of-Care Diagnostics Market for Hepatitis C Testing Products, by Region, 2018-2025 (USD Million)
6.4.4 Healthcare-Associated Infection Testing Products
6.4.4.1 Rising Prevalence of Hais is the Key Factor Driving Market Growth
Table 42 Point-Of-Care Diagnostics Market for Healthcare-Associated Infection Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 43 Point-Of-Care Diagnostics Market for Healthcare-Associated Infection Testing Products, by End-user, 2018-2025 (USD Million)
Table 44 Point-Of-Care Diagnostics Market for Healthcare-Associated Infection Testing Products, by Region, 2018-2025 (USD Million)
6.4.5 Influenza Testing Products
6.4.5.1 Rising Influenza Prevalence Has Driven the Demand for Influenza Testing Products
Table 45 Point-Of-Care Diagnostics Market for Influenza Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 46 Point-Of-Care Diagnostics Market for Influenza Testing Products, by End-user, 2018-2025 (USD Million)
Table 47 Point-Of-Care Diagnostics Market for Influenza Testing Products, by Region, 2018-2025 (USD Million)
6.4.6 Tropical Disease Testing Products
6.4.6.1 Increasing Government Funding for the Use of Poc in Tropical Disease Testing Will Support Market Growth
Table 48 Point-Of-Care Diagnostics Market for Tropical Disease Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 49 Point-Of-Care Diagnostics Market for Tropical Disease Testing Products, by End-user, 2018-2025 (USD Million)
Table 50 Point-Of-Care Diagnostics Market for Tropical Disease Testing Products, by Region, 2018-2025 (USD Million)
6.4.7 Sexually Transmitted Disease Testing Products
6.4.7.1 Privacy and Confidentiality Issues Are the Key Factors Leading to the Adoption of Poc Std Testing Products
Table 51 Point-Of-Care Diagnostics Market for Std Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 52 Point-Of-Care Diagnostics Market for Std Testing Products, by End-user, 2018-2025 (USD Million)
Table 53 Point-Of-Care Diagnostics Market for Std Testing Products, by Region, 2018-2025 (USD Million)
6.4.8 Other Infectious Disease Testing Products
Table 54 Point-Of-Care Diagnostics Market for Other Infectious Disease Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 55 Point-Of-Care Diagnostics Market for Other Infectious Disease Testing Products, by End-user, 2018-2025 (USD Million)
Table 56 Point-Of-Care Diagnostics Market for Other Infectious Disease Testing Products, by Region, 2018-2025 (USD Million)
6.5 Coagulation Monitoring Products
Table 57 Point-Of-Care Diagnostics Market for Coagulation Monitoring Products, by Type, 2018-2025 (USD Million)
Table 58 Point-Of-Care Diagnostics Market for Coagulation Monitoring Products, by Platform, 2018-2025 (USD Million)
Table 59 Point-Of-Care Diagnostics Market for Coagulation Monitoring Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 60 Point-Of-Care Diagnostics Market for Coagulation Monitoring Products, by End-user, 2018-2025 (USD Million)
Table 61 Point-Of-Care Diagnostics Market for Coagulation Monitoring Products, by Region, 2018-2025 (USD Million)
6.5.1 Pt/INR Testing Products
6.5.1.1 Pt/INR is One of the Most Commonly Used Coagulation Monitoring Methods
Table 62 Point-Of-Care Diagnostics Market for Pt/INR Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 63 Point-Of-Care Diagnostics Market for Pt/INR Testing Products, by End-user, 2018-2025 (USD Million)
Table 64 Point-Of-Care Diagnostics Market for Pt/INR Testing Products, by Region, 2018-2025 (USD Million)
6.5.2 Act/Aptt Testing Products
6.5.2.1 Rising Number of Patients Undergoing Angioplasty and Dialysis Globally to Support Market Growth
Table 65 Point-Of-Care Diagnostics Market for Act/Aptt Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 66 Point-Of-Care Diagnostics Market for Act/Aptt Testing Products, by End-user, 2018-2025 (USD Million)
Table 67 Point-Of-Care Diagnostics Market for Act/Aptt Testing Products, by Region, 2018-2025 (USD Million)
6.6 Pregnancy & Fertility Testing Products
Table 68 Point-Of-Care Diagnostics Market for Pregnancy & Fertility Testing Products, by Type, 2018-2025 (USD Million)
Table 69 Point-Of-Care Diagnostics Market for Pregnancy & Fertility Testing Products, by Platform, 2018-2025 (USD Million)
Table 70 Point-Of-Care Diagnostics Market for Pregnancy & Fertility Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 71 Point-Of-Care Diagnostics Market for Pregnancy & Fertility Testing Products, by End-user, 2018-2025 (USD Million)
Table 72 Point-Of-Care Diagnostics Market for Pregnancy & Fertility Testing Products, by Region, 2018-2025 (USD Million)
6.6.1 Pregnancy Testing Products
6.6.1.1 Rising Inclination Toward Home Testing to Support Market Growth
Table 73 Point-Of-Care Diagnostics Market for Pregnancy Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 74 Point-Of-Care Diagnostics Market for Pregnancy Testing Products, by End-user, 2018-2025 (USD Million)
Table 75 Point-Of-Care Diagnostics Market for Pregnancy Testing Products, by Region, 2018-2025 (USD Million)
6.6.2 Fertility Testing Products
6.6.2.1 Increasing Awareness of Fertility Testing to Drive Market Growth
Table 76 Point-Of-Care Diagnostics Market for Fertility Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 77 Point-Of-Care Diagnostics Market for Fertility Testing Products, by End-user, 2018-2025 (USD Million)
Table 78 Point-Of-Care Diagnostics Market for Fertility Testing Products, by Region, 2018-2025 (USD Million)
6.7 Tumor/Cancer Marker Testing Products
6.7.1 Increasing Investments for Research Related to Poc Cancer Testing Are Driving Market Growth
Table 79 Point-Of-Care Diagnostics Market for Tumor/Cancer Marker Testing Products, by Platform, 2018-2025 (USD Million)
Table 80 Point-Of-Care Diagnostics Market for Tumor/Cancer Marker Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 81 Point-Of-Care Diagnostics Market for Tumor/Cancer Marker Testing Products, by End-user, 2018-2025 (USD Million)
Table 82 Point-Of-Care Diagnostics Market for Tumor/Cancer Marker Testing Products, by Region, 2018-2025 (USD Million)
6.8 Urinalysis Testing Products
6.8.1 Rising Prevalence of Urinary Tract Infections is Driving Market Growth
Table 83 Point-Of-Care Diagnostics Market for Urinalysis Testing Products, by Platform, 2018-2025 (USD Million)
Table 84 Point-Of-Care Diagnostics Market for Urinalysis Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 85 Point-Of-Care Diagnostics Market for Urinalysis Testing Products, by End-user, 2018-2025 (USD Million)
Table 86 Point-Of-Care Diagnostics Market for Urinalysis Testing Products, by Region, 2018-2025 (USD Million)
6.9 Cholesterol Testing Products
6.9.1 Rising Obesity Levels & Cardiovascular Disorder Incidence Are the Key Factors Supporting Market Growth
Table 87 Point-Of-Care Diagnostics Market for Cholesterol Testing Products, by Platform, 2018-2025 (USD Million)
Table 88 Point-Of-Care Diagnostics Market for Cholesterol Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 89 Point-Of-Care Diagnostics Market for Cholesterol Testing Products, by End-user, 2018-2025 (USD Million)
Table 90 Point-Of-Care Diagnostics Market for Cholesterol Testing Products, by Region, 2018-2025 (USD Million)
6.1 Hematology Testing Products
6.10.1 Preference for Laboratory-Based Tests Among Users Will Impede Market Growth
Table 91 Point-Of-Care Diagnostics Market for Hematology Testing Products, by Platform, 2018-2025 (USD Million)
Table 92 Point-Of-Care Diagnostics Market for Hematology Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 93 Point-Of-Care Diagnostics Market for Hematology Testing Products, by End-user, 2018-2025 (USD Million)
Table 94 Point-Of-Care Diagnostics Market for Hematology Testing Products, by Region, 2018-2025 (USD Million)
6.11 Drugs-Of-Abuse Testing Products
6.11.1 Rising Consumption of Illicit Drugs Has Boosted Demand for Testing
Table 95 Point-Of-Care Diagnostics Market for Drugs-Of-Abuse Testing Products, by Platform, 2018-2025 (USD Million)
Table 96 Point-Of-Care Diagnostics Market for Drugs-Of-Abuse Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 97 Point-Of-Care Diagnostics Market for Drugs-Of-Abuse Testing Products, by End-user, 2018-2025 (USD Million)
Table 98 Point-Of-Care Diagnostics Market for Drugs-Of-Abuse Testing Products, by Region, 2018-2025 (USD Million)
6.12 Fecal Occult Testing Products
6.12.1 Lack of Proper Training in the Use of Fecal Occult Testing to Hamper Market Adoption
Table 99 Point-Of-Care Diagnostics Market for Fecal Occult Testing Products, by Platform, 2018-2025 (USD Million)
Table 100 Point-Of-Care Diagnostics Market for Fecal Occult Testing Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 101 Point-Of-Care Diagnostics Market for Fecal Occult Testing Products, by End-user, 2018-2025 (USD Million)
Table 102 Point-Of-Care Diagnostics Market for Fecal Occult Testing Products, by Region, 2018-2025 (USD Million)
6.13 Other Poc Products
Table 103 Point-Of-Care Diagnostics Market for Other Poc Products, by Platform, 2018-2025 (USD Million)
Table 104 Point-Of-Care Diagnostics Market for Other Products, by Mode of Purchase, 2018-2025 (USD Million)
Table 105 Point-Of-Care Diagnostics Market for Other Poc Products, by End-user, 2018-2025 (USD Million)
Table 106 Point-Of-Care Diagnostics Market for Other Poc Products, by Region, 2018-2025 (USD Million)
7 Point-Of-Care Diagnostics Market, by Platform
7.1 Introduction
Table 107 Point-Of-Care Diagnostics Market, by Platform, 2018-2025 (USD Million)
7.2 Lateral Flow Assays
7.2.1 Technological Advancements and Increasing Adoption of LFA Are Supporting Market Growth
Table 108 Point-Of-Care Diagnostics Market for Lateral Flow Assays, by Region, 2018-2025 (USD Million)
7.3 Immunoassays
7.3.1 Rising Incidence of Cancer and Growing Awareness About Immunoassay Platforms to Support Market Growth
Table 109 Point-Of-Care Diagnostics Market for Immunoassays, by Region, 2018-2025 (USD Million)
7.4 Microfluidics
7.4.1 Microfluidics is An Emerging Platform in the Poc Diagnostics Market
Table 110 Point-Of-Care Diagnostics Market for Microfluidics, by Region, 2018-2025 (USD Million)
7.5 Dipsticks
7.5.1 Dipsticks Help in the Routine Analysis of Several Medical Conditions
Table 111 Point-Of-Care Diagnostics Market for Dipsticks, by Region, 2018-2025 (USD Million)
7.6 Molecular Diagnostics
7.6.1 Increasing Initiatives by Market Players for Developing Poc Molecular Diagnostic Products to Drive Market Growth
Table 112 Point-Of-Care Diagnostics Market for Molecular Diagnostics, by Region, 2018-2025 (USD Million)
8 Point-Of-Care Diagnostics Market, by Mode of Purchase
8.1 Introduction
Table 113 Point-Of-Care Diagnostics Market, by Mode of Purchase, 2018-2025 (USD Million)
8.2 OTC Testing Products
8.2.1 Rising Focus on Home Care is Expected to Boost the Demand for OTC Testing in the Coming Years
Table 114 OTC Point-Of-Care Testing Products Market, by Region, 2018-2025 (USD Million)
8.3 Prescription-Based Testing Products
8.3.1 Growing Prevalence of Lifestyle Diseases and Favorable Reimbursement Have Driven Market Growth
Table 115 Prescription-Based Point-Of-Care Testing Products Market, by Region, 2018-2025 (USD Million)
9 Point-Of-Care Diagnostics Market, by End-user
9.1 Introduction
Table 116 Point-Of-Care Diagnostics Market, by End-user, 2018-2025 (USD Million)
9.2 Outpatient & Ambulatory Care Facilities
9.2.1 Rapid Result Generation and Availability of Immediate Patient Care Are the Major Factors Driving Market Growth
Table 117 Point-Of-Care Diagnostics Market for Outpatient & Ambulatory Care Facilities, by Region, 2018-2025 (USD Million)
9.3 Hospitals & Critical Care Centers
9.3.1 Hospitals Are Among the Largest End-users of Poc Diagnostics
Table 118 Point-Of-Care Diagnostics Market for Hospitals & Critical Care Centers, by Region, 2018-2025 (USD Million)
9.4 Home Care Settings
9.4.1 Increasing Inclination Toward Home Healthcare is Driving the Growth of this End-User Segment
Table 119 Point-Of-Care Diagnostics Market for Home Care Settings, by Region, 2018-2025 (USD Million)
9.5 Other End-users
Table 120 Point-Of-Care Diagnostics Market for Other End-users, by Region, 2018-2025 (USD Million)
10 Point-Of-Care Diagnostics Market, by Region
10.1 Introduction
Table 121 Point-Of-Care Diagnostics Market, by Region, 2018-2025 (USD Million)
10.2 North America
Figure 17 North America: Point-Of-Care Diagnostics Market Snapshot
Table 122 North America: Point-Of-Care Diagnostics Market, by Country, 2018-2025 (USD Million)
Table 123 North America: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
Table 124 North America: Point-Of-Care Diagnostics Market for Glucose Monitoring Products, by Type, 2018-2025 (USD Million)
Table 125 North America: Point-Of-Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2018-2025 (USD Million)
Table 126 North America: Point-Of-Care Diagnostics Market for Infectious Disease Testing Products, by Type, 2018-2025 (USD Million)
Table 127 North America: Point-Of-Care Diagnostics Market for Coagulation Monitoring Products, by Type, 2018-2025 (USD Million)
Table 128 North America: Point-Of-Care Diagnostics Market for Pregnancy & Fertility Testing Products, by Type, 2018-2025 (USD Million)
Table 129 North America: Point-Of-Care Diagnostics Market, by Platform, 2018-2025 (USD Million)
Table 130 North America: Point-Of-Care Diagnostics Market, by Mode of Purchase, 2018-2025 (USD Million)
Table 131 North America: Point-Of-Care Diagnostics Market, by End-user, 2018-2025 (USD Million)
10.2.1 US
10.2.1.1 The US Dominates the North American Market for Poc Diagnostics
Table 132 Us: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.2.2 Canada
10.2.2.1 Rising Government Initiatives to Support the Growth of the Poc Diagnostics Market in Canada
Table 133 Canada: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.3 Europe
Table 134 Europe: Point-Of-Care Diagnostics Market, by Country, 2018-2025 (USD Million)
Table 135 Europe: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
Table 136 Europe: Point-Of-Care Diagnostics Market for Glucose Monitoring Products, by Type, 2018-2025 (USD Million)
Table 137 Europe: Point-Of-Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2018-2025 (USD Million)
Table 138 Europe: Point-Of-Care Diagnostics Market for Infectious Disease Testing Products, by Type, 2018-2025 (USD Million)
Table 139 Europe: Point-Of-Care Diagnostics Market for Coagulation Monitoring Products, by Type, 2018-2025 (USD Million)
Table 140 Europe: Point-Of-Care Diagnostics Market for Pregnancy & Fertility Testing Products, by Type, 2018-2025 (USD Million)
Table 141 Europe: Point-Of-Care Diagnostics Market, by Platform, 2018-2025 (USD Million)
Table 142 Europe: Point-Of-Care Diagnostics Market, by Mode of Purchase, 2018-2025 (USD Million)
Table 143 Europe: Point-Of-Care Diagnostics Market, by End-user, 2018-2025 (USD Million)
10.3.1 Germany
10.3.1.1 Germany Accounts for the Largest Share of the European Market
Table 144 Germany: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.3.2 France
10.3.2.1 Growing Public-Private Collaborations for Product Development to Drive Market Growth
Table 145 France: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.3.3 UK
10.3.3.1 Growing Awareness of the Benefits Offered by Poc Diagnostics to Support Market Growth in the UK
Table 146 Uk: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.3.4 Italy
10.3.4.1 Rising Prevalence of Chronic Diseases in Italy to Drive the Demand for Point-Of-Care Diagnostics
Table 147 Italy: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.3.5 Spain
10.3.5.1 Increasing Funding for Research in Spain to Boost Market Growth
Table 148 Spain: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.3.6 Rest of Europe
Table 149 RoE: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.4 Asia-Pacific
Figure 18 APAC: Point-Of-Care Diagnostics Market Snapshot
Table 150 APAC: Point-Of-Care Diagnostics Market, by Country, 2018-2025 (USD Million)
Table 151 APAC: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
Table 152 APAC: Point-Of-Care Diagnostics Market for Glucose Monitoring Products, by Type, 2018-2025 (USD Million)
Table 153 APAC: Point-Of-Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2018-2025 (USD Million)
Table 154 APAC: Point-Of-Care Diagnostics Market for Infectious Disease Testing Products, by Type, 2018-2025 (USD Million)
Table 155 APAC: Point-Of-Care Diagnostics Market for Coagulation Monitoring Products, by Type, 2018-2025 (USD Million)
Table 156 APAC: Point-Of-Care Diagnostics Market for Pregnancy & Fertility Testing Products, by Type, 2018-2025 (USD Million)
Table 157 APAC: Point-Of-Care Diagnostics Market, by Platform, 2018-2025 (USD Million)
Table 158 APAC: Point-Of-Care Diagnostics Market, by Mode of Purchase, 2018-2025 (USD Million)
Table 159 APAC: Point-Of-Care Diagnostics Market, by End-user, 2018-2025 (USD Million)
10.4.1 Japan
10.4.1.1 Japan to Dominate the APAC Poc Diagnostics Market During the Forecast Period
Table 160 Japan: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.4.2 China
10.4.2.1 Rising Investments by Market Players and the Chinese Government to Drive Market Growth
Table 161 China: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.4.3 India
10.4.3.1 High Burden of Chronic Diseases to Support Market Growth
Table 162 India: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.4.4 Australia
10.4.4.1 High Burden of Chronic Diseases to Support Market Growth
Table 163 Australia: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.4.5 South Korea
10.4.5.1 Increased Funding and Product Development to Propel Market Growth
Table 164 South Korea: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.4.6 Rest of Asia-Pacific
Table 165 Roapac: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.5 Latin America
Table 166 Latam: Point-Of-Care Diagnostics Market, by Country, 2018-2025 (USD Million)
Table 167 Latam: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
Table 168 Latam: Point-Of-Care Diagnostics Market for Glucose Monitoring Products, by Type, 2018-2025 (USD Million)
Table 169 Latam: Point-Of-Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2018-2025 (USD Million)
Table 170 Latam: Point-Of-Care Diagnostics Market for Infectious Disease Testing Products, by Type, 2018-2025 (USD Million)
Table 171 Latam: Point-Of-Care Diagnostics Market for Coagulation Monitoring Products, by Type, 2018-2025 (USD Million)
Table 172 Latam: Point-Of-Care Diagnostics Market for Pregnancy & Fertility Testing Products, by Type, 2018-2025 (USD Million)
Table 173 Latam: Point-Of-Care Diagnostics Market, by Platform, 2018-2025 (USD Million)
Table 174 Latam: Point-Of-Care Diagnostics Market, by Mode of Purchase, 2018-2025 (USD Million)
Table 175 Latam: Point-Of-Care Diagnostics Market, by End-user, 2018-2025 (USD Million)
10.5.1 Brazil
10.5.1.1 Rising Prevalence of Diabetes to Support Market Growth in Brazil
Table 176 Brazil: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.5.2 Mexico
10.5.2.1 Rising Prevalence of Diabetes and Cancer to Support Market Growth in Mexico
Table 177 Mexico: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.5.3 Rest of Latin America
Table 178 Rolatam: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
10.6 Middle East & Africa
10.6.1 Rising Prevalence of Cancer to Support Market Growth in the Mea
Table 179 Middle East & Africa: Point-Of-Care Diagnostics Market, by Product, 2018-2025 (USD Million)
Table 180 Middle East & Africa: Point-Of-Care Diagnostics Market for Glucose Monitoring Products, by Type, 2018-2025 (USD Million)
Table 181 Middle East & Africa: Point-Of-Care Diagnostics Market for Cardiometabolic Monitoring Products, by Type, 2018-2025 (USD Million)
Table 182 Middle East & Africa: Point-Of-Care Diagnostics Market for Infectious Disease Testing Products, by Type, 2018-2025 (USD Million)
Table 183 Middle East & Africa: Point-Of-Care Diagnostics Market for Coagulation Monitoring Products, by Type, 2018-2025 (USD Million)
Table 184 Middle East & Africa: Point-Of-Care Diagnostics Market for Pregnancy & Fertility Testing Products, by Type, 2018-2025 (USD Million)
Table 185 Middle East & Africa: Point-Of-Care Diagnostics Market, by Platform, 2018-2025 (USD Million)
Table 186 Middle East & Africa: Point-Of-Care Diagnostics Market, by Mode of Purchase, 2018-2025 (USD Million)
Table 187 Middle East & Africa: Point-Of-Care Diagnostics Market, by End-user, 2018-2025 (USD Million)
11 Competitive Landscape
11.1 Overview
Figure 19 Key Developments in the Point-Of-Care Diagnostics Market (2017-2020)
11.2 Market Share Analysis (2019)
Figure 20 Roche Diagnostics Held the Leading Position in the Market in 2019
11.3 Competitive Scenario (2016-2020)
Figure 21 Strategic Overview: Major Players (2016-2020)
11.3.1 Key Product Launches & Product Approvals (2016-2020)
11.3.2 Key Acquisitions (2016-2020)
11.3.3 Key Agreements, Contracts, and Partnerships (2016-2020)
11.4 Competitive Leadership Mapping: Major Global Players (As of 2019)
11.4.1 Stars
11.4.2 Emerging Leaders
11.4.3 Pervasive Players
11.4.4 Participants
Figure 22 Point-Of-Care Diagnostics Market: Competitive Leadership Mapping, 2019 (Major Global Players)
11.5 Competitive Leadership Mapping: Emerging Companies/SMEs/Start-Ups (As of 2019)
11.5.1 Progressive Companies
11.5.2 Starting Blocks
11.5.3 Responsive Companies
11.5.4 Dynamic Companies
12 Company Profiles
(Business Overview, Products Offered, Recent Developments, Analyst's View)*
12.1 Roche Diagnostics
Figure 24 Roche Diagnostics: Company Snapshot
12.2 Siemens Healthineers
Figure 25 Siemens Healthineers: Company Snapshot
12.3 Danaher Corporation
Figure 26 Danaher Corporation: Company Snapshot
12.4 Becton, Dickinson and Company
Figure 27 Becton, Dickinson and Company: Company Snapshot
12.5 Abbott Laboratories
Figure 28 Abbott Laboratories: Company Snapshot
12.6 Quidel Corporation
Figure 29 Quidel Corporation: Company Snapshot
12.7 Chembio Diagnostics
Figure 30 Chembio Diagnostics: Company Snapshot
12.8 Johnson & Johnson
Figure 31 Johnson & Johnson: Company Snapshot
12.9 EKF Diagnostics
Figure 32 EKF Diagnostics: Company Snapshot
12.10 Trinity Biotech
Figure 33 Trinity Biotech: Company Snapshot
12.11 Accubiotech
12.12 Instrumentation Laboratory (A Werfen Company)
12.13 Nova Biomedical
12.14 PTS Diagnostics
12.15 Sekisui Diagnostics
12.16 Fluxergy
*Business Overview, Products Offered, Recent Developments, Analyst's View Might Not be Captured in Case of Unlisted Companies.
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: The Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details
Note: Product cover images may vary from those shown
  • A. Menarini Diagnostics S.R.L
  • Abbott
  • Accubiotech Co., Ltd.
  • Acon Laboratories, Inc.
  • Ascensia Diabetes Care Holdings Ag
  • Becton, Dickinson and Company
  • Biocartis
  • Biomérieux S.A.
  • Chembio Diagnostics, Inc.
  • Danaher Corporation
  • Diasorin S.P.A.
  • Ekf Diagnostics
  • F. Hoffmann-La Roche Ltd.
  • Fluxergy
  • Genestat Molecular Diagnostics, LLC.
  • Grifols, S.A.
  • Instrumentation Laboratory (A Werfen Company)
  • Lifescan Ip Holdings, LLC
  • Mankind Pharma
  • Meridian Bioscience
  • Nova Biomedical
  • Orasure Technologies, Inc.
  • Prescision Biosensor, Inc.
  • Pts Diagnostics
  • Quidel Corporation
  • Sekisui Diagnostics
  • Siemens Healthineers Ag
  • Terumo Corporation
  • Thermo Fisher Scientific
  • Trinity Biotech plc
Note: Product cover images may vary from those shown

Loading
LOADING...